Basilea Pharmaceutica
BSLN.SW
#6394
Rank
NZ$1.01 B
Marketcap
$83.65
Share price
-5.97%
Change (1 day)
18.94%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: $1.84

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is $1.84. In 2023 the company made an earnings per share (EPS) of $1.84 a decrease over its 2022 EPS that were of $1.96.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.84-6.28%
2022$1.96-273.94%
2021-$1.13-60.87%
2020-$2.88-24.46%
2019-$3.82-26.92%
2018-$5.2259.83%
2017-$3.27-63.06%
2016-$8.85-19.26%
2015-$10.9546.12%
2014-$7.5010.07%
2013-$6.81-36.76%
2012-$10.77-5.42%
2011-$11.39-153.36%
2010$21.34-198.47%
2009-$21.67-15.34%
2008-$25.6016.7%
2007-$21.9336.07%
2006-$16.1279.07%
2005-$9.00-46.79%
2004-$16.919.83%
2003-$15.40-34.23%
2002-$23.42